XtalPi 推出 Kodexia，其用于六个 siRNA 项目的平台

联合创始人 Jian Ma、Shuhao Wen 和 Lipeng Lai 正将 XtalPi 的物理与自动化方法扩展到 RNA 药物领域，不过其关于内部性能的宣称仍需经受验证以证明其价值。

By · Published

Primary source: PR Newswire

为何重要

Kodexia 将 XtalPi 的物理学与自动化方法扩展到 siRNA 领域。其六个内部项目为创始人提供了直接检验该平台关于设计速度主张是否能够产出候选药物的机会。

A generic biotech lab bench shows a double-stranded RNA model, six sample tubes and automated pipetting equipment, illustrating XtalPi’s RNAi programs.

XtalPi, co-founded by Jian Ma, Shuhao Wen and Lipeng Lai, has put six proprietary siRNA drug programs behind Kodexia, a platform combining generative AI, biological modeling and automated lab work.…

When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.

Reader comments

Conversation for this story loads after sign-in.